Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China flag China · Delayed Price · Currency is CNY
29.36
-0.24 (-0.81%)
At close: Jan 21, 2026

SHA:688443 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
10,5799,20014,649---
Upgrade
Market Cap Growth
9.90%-37.20%----
Upgrade
Enterprise Value
9,3107,40512,246---
Upgrade
Last Close Price
28.8525.0939.95---
Upgrade
PS Ratio
46.98305.7012091.50---
Upgrade
PB Ratio
5.924.335.26---
Upgrade
P/TBV Ratio
6.064.425.35---
Upgrade
EV/Sales Ratio
41.35246.0410108.38---
Upgrade
Debt / Equity Ratio
0.590.390.2326.891.83-0.93
Upgrade
Asset Turnover
0.070.010.0000.050.00
Upgrade
Inventory Turnover
0.240.11-0.040.800.05
Upgrade
Quick Ratio
7.0714.1221.332.275.150.13
Upgrade
Current Ratio
7.5915.0522.153.166.150.22
Upgrade
Return on Equity (ROE)
-28.18%-32.47%-56.97%-337.99%--
Upgrade
Return on Assets (ROA)
-12.42%-15.62%-21.82%-38.85%-25.14%-45.69%
Upgrade
Return on Capital Employed (ROCE)
-23.20%-28.30%-23.00%-73.10%-32.90%-1923.60%
Upgrade
Earnings Yield
-5.52%-8.67%-5.47%---
Upgrade
FCF Yield
-4.54%-6.75%-3.20%---
Upgrade
Buyback Yield / Dilution
-0.03%-14.63%-16.79%0.32%--
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.